Characteristics of medical costs and resource use in patients with rheumatoid arthritis treated with and without glucocorticoids.
<h4>Objectives</h4>To evaluate medical costs and resource use in patients with rheumatoid arthritis (RA) treated with and without oral or injectable glucocorticoids (GCs) as part of their initial treatment with disease-modifying antirheumatic drugs (DMARDs).<h4>Methods</h4>Pa...
Saved in:
| Main Authors: | Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Katsuhiko Iwasaki, Ayako Shoji, Masayoshi Harigai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0329313 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of medical costs and resource use in patients with rheumatoid arthritis treated with and without glucocorticoids
by: Eiichi Tanaka, et al.
Published: (2025-01-01) -
Medical costs for patients with rheumatoid arthritis who have comorbid diabetes mellitus.
by: Eiichi Tanaka, et al.
Published: (2025-01-01) -
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry
by: Masayoshi Harigai, et al.
Published: (2024-07-01) -
Health economic evaluation of self-injection of biologics in patients with rheumatoid arthritis using a Japanese real-world web-based survey
by: Kazuhiko Takahata, et al.
Published: (2025-05-01) -
Trends in the idea of the safety of glucocorticoids in rheumatoid arthritis
by: Yu V Murav'ev, et al.
Published: (2011-04-01)